Resources

For the latest in precision medicine, sign up for our monthly newsletter to be among the first to receive
exclusive insights, in-depth market analyses, and expert articles directly to your inbox

Spatial Analysis

The Molecular Landscape of SARS CoV 2 Infection in Tissue - A Multi Omic Approach

Presented by Tony Zucca, NanoString Technologies & Matthew Pugh, University of Birmingham
Spatial Analysis

Spatial Omics: Advancements and Use

Spatial omics is changing how we think about biology, giving us an unprecedented view into single cells and tissues.
Genome Editing

Synthetic Gene Circuits & Their Relevance To The Challenges Of Genome Editing

In Conversation With Gabor Balazsi, Henry Laufer Professor, Stony Brook University
Biomarker Discovery & Development

Implementing Flow Cytometry Assays In Biomarker Research

Oxford Global’s Discussion Groups provide a focused networking opportunity for a select group of like-minded experts on a monthly basis. Our first Biomarkers Discussion Group addressing ‘Implementing Flow Cytometry Assays In Biomarker Research’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
DPCR

Using ddPCR to Assess Gene Editing Therapies

When gene therapy goes wrong, it can have severe consequences. Dr Giandomenico Turchiano tells us how he can use ddPCR to catch those mistakes
Digital Biomarkers

Digital Biomarkers – An Industry Game Changer

This commentary article looks at the latest applications in digital and wearable biomarkers, with industry and academic insights from GlaxoSmithKline, Roche, and University College London.
Spatial Analysis

Spatial Genomics with Illumina Sequencing & NanoString GeoMx® Digital Spatial Profiler

Presented by Wes Goldman, NanoString | Bo Liu, Illumina | Cynthia Lebeaupin, Sanford Prebys Medical Discovery Institute | Jessica Noll, UC Riverside
Digital Biomarkers

Overcoming the Regulatory Challenges of Digital Health Technologies

Dr Derek Hill, Professor of Digital Health at University College London, on making the most of digital biomarkers and achieving clinical endpoints.
Diagnostic Development

Non-invasive Early Disease Detection and Precision Medicine Using Breath Biomarkers

Breath is the ideal biomarker matrix for the future of diagnostics. Sample collection is non-invasive, painless and easy to perform, and breath is a rich source of potential biomarkers. Potential applications for breath tests include disease detection, phenotyping, progression and treatment monitoring, and complementary diagnostics. Discover the benefits and capabilities of breath testing, and start researching breath biomarkers with Breath Biopsy®.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery